title: The 3 + 3 dose escalation design is not appropriate for antivenom dose finding.
authors.forename: Jean-Philippe
authors.initials: JP
authors.lastname: Chippaux
authors.forename: Leslie
authors.initials: L
authors.lastname: Boyer
mesh_terms: D000997:Antivenins / Q000008:administration & dosage* / Q000009:adverse effects* / Q000627:therapeutic use*; D017321:Clinical Trials, Phase I as Topic; D004305:Dose-Response Relationship, Drug; D006801:Humans; D020714:Maximum Tolerated Dose; D012107:Research Design; D018570:Risk Assessment; D012909:Snake Bites / Q000188:drug therapy
chemical_list: D000997:Antivenins